(Q40826649)

24 September 2017

title

The impact of the Dialysis Outcomes Quality Initiative Guidelines on the care of the pediatric end-stage renal disease patient (English)

1 reference

24 September 2017

0 references

Jabs K

1

1 reference

24 September 2017

Warady BA

series ordinal

2

1 reference

24 September 2017

publication date

1 January 1999

1 reference

Advances in Chronic Kidney Disease

24 September 2017

language of work

1 reference

24 September 2017

volume

6

1 reference

24 September 2017

issue

1

1 reference

24 September 2017

page(s)

97-106

1 reference

Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

The dose of hemodialysis and patient mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

Development of a population-specific regression equation to estimate total body water in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

The Assessment of Body Water and Fatness from Infancy to Adulthood

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

Mathematical modelling of haemodialysis in children

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

Paediatric haemodialysis: estimation of treatment efficiency in the presence of urea rebound

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

Effects of dose of dialysis on morbidity and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

Assessing renal function from creatinine measurements in adults with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

Estimation of peritoneal mass transport by three-pore model in children

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

Hemodialysis-associated subclavian vein stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

Post Catheterisation Vein Stenosis in Haemodialysis: Comparative Angiographic Study of 50 Subdavian and 50 Internal Jugular Accesses

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

Comparison of autogenous fistula versus expanded polytetrafluoroethylene graft fistula for angioaccess in hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

Benefits and risks of anemia correction with recombinant human erythropoietin in children maintained by hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

Non-cardiac benefits of human recombinant erythropoietin in end stage renal failure and anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

Recombinant human erythropoietin therapy in pediatric patients receiving long-term peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

The safety of intravenous iron dextran in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1073-4449%2899%2970016-6

7 January 2021

10.1016/S1073-4449(99)70016-6

Identifiers

DOI

0 references

1 reference